The Association of Visceral Adiposity Index with the Risk of Kidney Stone and Kidney Stone Recurrence

Overview

Journal BMC Nephrol

Publisher Biomed Central

Specialty Nephrology

Date 2023 Dec 13

PMID 38087224

Authors

Dan Liang

Chang Liu

Mei Yang

Affiliations

Soon will be listed here.

Abstract

Aim: Our aim in this study was primarily to assess the relationship between visceral adiposity index (VAI) and the risk of kidney stones and kidney stone recurrence in US adults.

Methods: We used data from the National Health and Nutrition Examination Survey (NHANES) 2007-2014 for our analysis. VAI was calculated from waist circumference (WC), body mass index (BMI), triglycerides (TG), and high-density lipoprotein-cholesterol (HDL-C). Kidney stones and recurrence of kidney stones were obtained from questionnaire interview data. We used multivariate logistic regression analysis to explore the correlation between VAI and the risk of kidney stone and kidney stone recurrence. In addition, we performed subgroup analysis, interaction tests, and restricted cubic spline (RCS) analysis.

Results: A total of 9886 participants were included in this study, with a prevalence of 9.24% for kidney stones and 2.97% for recurrence of kidney stones. The prevalence of kidney stones and kidney stone recurrence increased with higher quartiles of VAI. We observed a significantly positive correlation between VAI and the risk of kidney stone and kidney stone recurrence. Participants with the highest VAI quartiles had a 48% (OR: 1.48, 95%CI: 1.08-2.02) and 52% (OR: 1.52, 95%CI: 0.86-2.71) increased risk of kidney stones and kidney stone recurrence, respectively, compared to participants with the lowest VAI quartiles. Subgroup analysis and interaction tests demonstrated this positive association independent of different subgroup factors.

Conclusion: Visceral fat accumulation may be associated with an increased risk of kidney stones and kidney stone recurrence.

Citing Articles

The relationship between visceral adipose tissue and osteoarthritis among older adults: evidence from the NHANES 1999-2018.

Huang W, Xiao Y, Zou Y, Zhong L, Huang G Front Nutr. 2025; 12:1526377.

PMID: 39973921 PMC: 11835674. DOI: 10.3389/fnut.2025.1526377.

The atherogenic index of plasma increases the risk of incident kidney stones: a nested case-control study in Chinese adults.

Wang D, Shi F, Zhang D, Wang H, Zhu Y, Wang J Ren Fail. 2025; 47(1):2458757.

PMID: 39904806 PMC: 11800335. DOI: 10.1080/0886022X.2025.2458757.

Perspective from NHANES data: synergistic effects of visceral adiposity index and lipid accumulation products on diabetes risk.

He J, Chen L Sci Rep. 2025; 15(1):258.

PMID: 39747273 PMC: 11696142. DOI: 10.1038/s41598-024-84034-7.

Association between insulin resistance indices and kidney stones: results from the 2015-2018 National Health and Nutrition Examination Survey.

Shen Y, Zhu Z, Bi X, Shen Y, Shen A, Deng B Front Nutr. 2024; 11:1444049.

PMID: 39416649 PMC: 11480067. DOI: 10.3389/fnut.2024.1444049.

Relationship between the atherogenic index of plasma and the prevalence of kidney stones: insights from a population-based cross-sectional study.

Wang D, Shi F, Zhang D, Zhang L, Wang H, Zhou Z Ren Fail. 2024; 46(2):2390566.

PMID: 39230050 PMC: 11376308. DOI: 10.1080/0886022X.2024.2390566.

References

Kouli G, Panagiotakos D, Kyrou I, Georgousopoulou E, Chrysohoou C, Tsigos C . Visceral adiposity index and 10-year cardiovascular disease incidence: The ATTICA study. Nutr Metab Cardiovasc Dis. 2017; 27(10):881-889. DOI: 10.1016/j.numecd.2017.06.015. View

Ou Y, Lee M, Lin I, Wen W, Hsu W, Chen S . Obesity-related indices are associated with albuminuria and advanced kidney disease in type 2 diabetes mellitus. Ren Fail. 2021; 43(1):1250-1258. PMC: 8409948. DOI: 10.1080/0886022X.2021.1969247. View

Perez-Lasierra J, Casajus J, Gonzalez-Aguero A, Moreno-Franco B . Association of physical activity levels and prevalence of major degenerative diseases: Evidence from the national health and nutrition examination survey (NHANES) 1999-2018. Exp Gerontol. 2021; 158:111656. DOI: 10.1016/j.exger.2021.111656. View

Yan L, Zeng Y, Chan-Shan Ma R, Zheng Y . J-shaped association between the visceral adiposity index and all-cause mortality in patients with chronic kidney disease. Nutrition. 2022; 103-104:111832. DOI: 10.1016/j.nut.2022.111832. View

Fang T, Zhang Q, Wang Y, Zha H . Diagnostic value of visceral adiposity index in chronic kidney disease: a meta-analysis. Acta Diabetol. 2023; 60(6):739-748. DOI: 10.1007/s00592-023-02048-5. View

Taguchi K, Okada A, Hamamoto S, Iwatsuki S, Naiki T, Ando R . Proinflammatory and Metabolic Changes Facilitate Renal Crystal Deposition in an Obese Mouse Model of Metabolic Syndrome. J Urol. 2015; 194(6):1787-96. DOI: 10.1016/j.juro.2015.07.083. View

Kelly C, Geraghty R, Somani B . Nephrolithiasis in the Obese Patient. Curr Urol Rep. 2019; 20(7):36. DOI: 10.1007/s11934-019-0898-0. View

Zhang Y, He Q, Zhang W, Xiong Y, Shen S, Yang J . Non-linear Associations Between Visceral Adiposity Index and Cardiovascular and Cerebrovascular Diseases: Results From the NHANES (1999-2018). Front Cardiovasc Med. 2022; 9:908020. PMC: 9263190. DOI: 10.3389/fcvm.2022.908020. View

Liu C, Tsai Y, Huang H . Atorvastatin Decreases Renal Calcium Oxalate Stone Deposits by Enhancing Renal Osteopontin Expression in Hyperoxaluric Stone-Forming Rats Fed a High-Fat Diet. Int J Mol Sci. 2022; 23(6). PMC: 8954580. DOI: 10.3390/ijms23063048. View

10.

Fryar C, Ostchega Y, Hales C, Zhang G, Kruszon-Moran D . Hypertension Prevalence and Control Among Adults: United States, 2015-2016. NCHS Data Brief. 2017; (289):1-8. View

11.

Wang J, Jin X, Chen K, Yan W, Wang A, Zhu B . Visceral adiposity index is closely associated with urinary albumin-creatinine ratio in the Chinese population with prediabetes. Diabetes Metab Res Rev. 2020; 37(7):e3424. DOI: 10.1002/dmrr.3424. View

12.

Otunctemur A, Dursun M, Ozer K, Horsanali O, Ozbek E . Renal Cell Carcinoma and Visceral Adipose Index: a new risk parameter. Int Braz J Urol. 2016; 42(5):955-959. PMC: 5066891. DOI: 10.1590/S1677-5538.IBJU.2015.0396. View

13.

Khan S, Pearle M, Robertson W, Gambaro G, Canales B, Doizi S . Kidney stones. Nat Rev Dis Primers. 2016; 2:16008. PMC: 5685519. DOI: 10.1038/nrdp.2016.8. View

14.

West B, Luke A, Durazo-Arvizu R, Cao G, Shoham D, Kramer H . Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988-1994. Am J Kidney Dis. 2008; 51(5):741-7. DOI: 10.1053/j.ajkd.2007.12.030. View

15.

Dhondup T, Kittanamongkolchai W, Vaughan L, Mehta R, Chhina J, Enders F . Risk of ESRD and Mortality in Kidney and Bladder Stone Formers. Am J Kidney Dis. 2018; 72(6):790-797. PMC: 6252145. DOI: 10.1053/j.ajkd.2018.06.012. View

16.

Rukin N, Siddiqui Z, Chedgy E, Somani B . Trends in Upper Tract Stone Disease in England: Evidence from the Hospital Episodes Statistics Database. Urol Int. 2016; 98(4):391-396. DOI: 10.1159/000449510. View

17.

Menke A, Casagrande S, Geiss L, Cowie C . Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012. JAMA. 2015; 314(10):1021-9. DOI: 10.1001/jama.2015.10029. View

18.

Zhou C, Zhang Y, Yang S, He P, Wu Q, Ye Z . Associations between visceral adiposity index and incident nephropathy outcomes in diabetic patients: Insights from the ACCORD trial. Diabetes Metab Res Rev. 2022; 39(3):e3602. DOI: 10.1002/dmrr.3602. View

19.

Mosli H, Mosli H, Kamal W . Kidney stone composition in overweight and obese patients: a preliminary report. Res Rep Urol. 2014; 5:11-5. PMC: 3826902. DOI: 10.2147/RRU.S39581. View

20.

Amato M, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M . Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010; 33(4):920-2. PMC: 2845052. DOI: 10.2337/dc09-1825. View